4.6.0.0 Be­yond Glycemic Con­trol

Al­though hy­per­glycemia con­trol may be im­por­tant in older in­di­vid­u­als with di­a­betes, greater re­duc­tions in mor­bid­i­ty and mor­tal­i­ty are like­ly to re­sult from con­trol of other cardiovas­cu­lar risk fac­tors rather than from tight glycemic con­trol alone. There is strong ev­i­dence from clin­i­cal tri­als of the value of treat­ing hy­per­ten­sion in older adults (29,30). There is less ev­i­dence for lipid-‍low­er­ing ther­a­py and as­pirin ther­a­py, al­though the benefits of these in­ter­ven­tions for pri­ma­ry pre­vention and sec­ondary in­ter­ven­tion are like­ly to apply to older adults whose life ex­pectan­cies equal or ex­ceed the time frames of the clin­i­cal tri­als.